Cheap Ozempic is coming: Cost could soon be slashed for millions of Americans, drugmaker confirms — here’s how

In an emailed statement, a Novo Nordisk agent informed Quartz: “We can’t hypothesize on which Novo Nordisk medications will certainly be selected for future arrangements with [the] Centers for Medicare and Medicaid Services (CMS). We have actually opposed government cost establishing with the Inflation Reduction Act (IRA) and have severe issues regarding just how the law is being applied.”

In his U.S.A. Today op-ed, Head of state Biden specifically called out the manufacturers of Ozempic for their cost gouging tactics, creating: “Novo Nordisk is charging the American people unconscionably high rates for these prescription medicines. If your physician suggests you a GLP-1, the rates of Ozempic and Wegovy can be up to 6 times greater than prices in Canada, Germany, Denmark, and various other major nations. That’s undesirable.”

Novo Nordisk, the Danish pharmaceutical business that produces Ozempic, stated that it is “likely” the cost of the prominent diabetes-turned-weight loss medication will certainly be reduced in the second round of Medicare medicine cost negotiations.

In April, the Board on Health And Wellness, Education And Learning, Labor, and Pension Plans (HELP) introduced an investigation right into Ozempic pricing. Aid found the internet price of the drug in the U.S. is substantially greater than in various other countries.

Ulrich Otte, the business’s senior vice head of state of money and operations, made the insurance claim at the Cantor Global Healthcare Meeting in New York earlier this week, claiming: “It is very likely that Ozempic will become part of settlements in the coming round, and we await that.”